We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Ondine Biomedical Inc (OBI) NPV

Sell:11.50p Buy:12.00p 0 Change: 0.75p (6.82%)
Market closed |  Prices as at close on 17 June 2025 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:11.50p
Buy:12.00p
Change: 0.75p (6.82%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 17 June 2025 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:11.50p
Buy:12.00p
Change: 0.75p (6.82%)
Market closed |  Prices as at close on 17 June 2025 Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Open:
11.00p
Trade high:
12.00p
Year high:
13.30p
Market capitalisation
Market cap.
:
£52.08 million
Previous close:
11.00p
Trade low:
10.90p
Year low:
5.63p
P/E ratio:
n/a
Previous:
0.50p (4.76%) Previous:
0.50p
Volume:
117,853
Dividend yield:
n/a
EMS:
20,000
Data delayed by at least 15 minutes.
* UK residents can qualify for a reduced rate of Canadian tax on dividends and interest. In order to claim this reduced rate on your behalf we require you to sign and return a W-8BEN form. W-8BEN.

Share chart Chart

ONDINE BIOMED performance chart

Performance

1 week 1W 22.22% 1 year 1Y 46.67%
1 month 1M 33.33% 2 years 2Y 29.03%
3 months 3M 12.82% 3 years 3Y 74.12%
6 months 6M 41.94% 5 years 5Y n/a

Performance figures are based on the previous close price. Past performance is not an indication of future performance.

Fundamental data

Year ending: 31/12/2023 31/12/2022
Revenue ($m) 1.20 0.64
Profit before tax ($m) (14.41) (19.37)
Adjusted EPS (¢): (7.00) (10.00)
P/E ratio n/a n/a
PEG n/a n/a
EPS growth (%) n/a n/a

Values are quoted in the stock's local currency: US dollar

All fundamental data

Dividend information for this stock is not available.

Dividend information for this stock is not available.

Ready to invest?

Invest now

Want to invest?

To buy shares in , you'll need to have an account.

Explore the options

Important Documents

There are no documents available for this stock.

All company news
All company announcements

Annual & interim reports

Annual & interim reports are not available for this stock.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Prices provided by NBTrader. Charts provided by Factset. News and fundamental data provided by Digital Look.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.